HUNTINGTON — St. Mary’s Medical Center, part of Marshall Health Network, is launching a new COPD Community Screening Program ...

A woman from Somerset is urging others to trust their instincts and to continue pushing for medical appointments after an uneasy feeling about her family medical history and a “niggly” cough led to ...

Two pivotal Phase 3 trials of Haduvio are expected to launch this year and, if positive, may support applications seeking its ...

A chest infection feels like a temporary illness. A few days of coughing, fever, and fatigue, followed by medication, and life returns to normal. But .

New research suggests millions taking GLP-1 weight-loss injections could also face a greater risk of developing a chronic cough.

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients ...

The Company will conduct two Phase 3 clinical trials of nalbuphine ER for the treatment of patients with IPF-related chronic cough First pivotal trial is on track to initiate in the second quarter of ...

Dr Punam Krishan has explained the symptoms of COPD that could be easily overlooked - and recommended you should see a doctor ...

A highly contagious respiratory virus, HMPV, is spreading on the West Coast and beyond. Experts warn of symptoms, severe ...

Dr Punam Krishan said two patients came to her this week with a persistent cough and it turned out to be chronic lung disease ...

Flu, Covid, RSV and HMPV rising in NJ? Here's what to know about human metapneumovirus symptoms and why there may be no ...

Leerink Partners 2026 Global Healthcare Conference March 8 – 11, 2026, Miami, Florida Fireside Chat: March 11, 8:40 a.m. ET Trevi Representatives: Jennifer Good, President and CEO, and James Cassella, ...